Samsung BioLogics, a contract manufacturer of biologic drugs under Samsung Group, has denied accusations that it engaged in fraudulent
See Original Article

Proposed Accounting Standards Update—Technical Corrections and Improvements to Update No. 2014-09, Revenue from Contracts with Customers
See Original Article

John Herbst, former U.S. ambassador to Ukraine, discusses the future of U.S.-Russia relations. He speaks with Bloomberg's Joe Weisenthal and
See Original Article

… both parties agree on that one thing,” said Joe Baratta, Blackstone's global head of private equity, during a Bloomberg TV interview in late January.
See Original Article

Keep up with the best of Bloomberg Politics. … a.m. Thursday in Jakarta, according to Inter Dealer Market Association prices compiled by Bloomberg.
See Original Article